Moolec Science (MLEC) Cash & Equivalents (2022 - 2026)

Moolec Science (MLEC) has 5 years of Cash & Equivalents data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $767919.0, down 98.55% from the prior year.
• Cash & Equivalents grew to $1.2 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $228.0 million in Q1 2023 to a low of $767919.0 in Q2 2025.
• A 5-year average of $37.7 million and a median of $10.4 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 372.37% in 2023 and tumbled 98.55% in 2025, its largest moves.
• Tracing MLEC's Cash & Equivalents over 5 years: stood at $10.4 million in 2022, then surged by 372.37% to $49.3 million in 2023, then rose by 7.57% to $53.0 million in 2024, then plunged by 98.11% to $1.0 million in 2025, then climbed by 20.0% to $1.2 million in 2026.
• Business Quant data shows MLEC's Cash & Equivalents at $1.2 million in Q1 2026, $1.0 million in Q4 2025, and $767919.0 in Q2 2025.